UBC in the News: Factoring in Pharmacogenomics

Tailoring treatment to a patient’s genetic variations can have profound impacts on patient outcomes. Through pharmacogenomics, linkages between specific biomarkers and their underlying genotypes are identified. Then, drug treatments can be tailored to achieve optimal patient outcomes and minimize adverse reactions.

With these advances, comes the need for a different approach to clinical trials.

Subscribe to RSS - ASCO